🔎 Trials Near Me

Akèy › Maladi tiwoyid

Etid klinik pou Maladi tiwoyid ap rekrite nan Etazini

10 etid pou Maladi tiwoyid ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04913285

Study of BHV-1300 in Graves' Disease

Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jul 31, 2026 · NCT06980649

Hereditary Risk Factors for Thyroid Cancer

Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 11, 2026 · NCT02747888

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT05733013

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT04615988

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2025 · NCT03977207

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2025 · NCT06112340

Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease

Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 17, 2019 · NCT03050762

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.